German Cancer Aid Award for Galina Selivanova

Published 2015-08-19 15:19. Updated 2017-07-06 14:48

Galina Selivanova has been awarded  20, 000 Euros from German Cancer Aid (Stiftung Für Die Erforschung ung Bekämpfung der Krebsklarnkheiten) for research described in the paper "ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis" published in Cell Death Differ, April 2014

German Cancer Aid is Germany’s leading non-governmental funding and non-profit-making organization of oncology-related activities.

 

More information

ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis.
Shi Y, Nikulenkov F, Zawacka-Pankau J, Li H, Gabdoulline R, Xu J, et al
Cell Death Differ. 2014 Apr;21(4):612-23

German Cancer Aid website

Galina Selivanova research group website